Tim Wang

Company: Duality Biologics

Job title: Chief Business Officer

Bio:

Mr Wang, CFA, is Chief Business Officer of Duality Biologics. From October 1997 to December 2002, Mr. Wang worked in drug research and development at Schering-Plough, during which time he invented five patents.
After obtaining his MBA, he has accumulated nearly 20 years of experience in medical market research and corporate advisory in the banking field. Mr. Wang joined Thomas Weisel Partners LLC’s biotechnology market research team as an associate analyst in January 2003, and then joined JP Morgan Securities in March 2004 to research large pharmaceutical companiet. In the same year, he joined UBS Securities LLC with the team and continued to be responsible for pharmaceutical research. In March 2007, Mr. Wang joined Mizuho Bank as vice president, mainly responsible for research and analysis, and advised on industries such as pharmaceuticals and biotechnology. He has also served as director, senior vice president and other positions. His last position when he left Mizuho Bank in September 2021 was executive director.

Seminars:

ADC Deal-Making: Will Success Lead to More Success? 2:10 pm

Discussing opportunity for and examples of creative deal structures across ADCs  For payloads: Do you need the full ADC payload for a deal? For linkers: What drives deals with different types of linkers?  For target discovery: What are the differences in deal structure versus linkers and payloads? Sharing guidance to progress from a research collaboration…Read more

day: Conference Day Two